![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 12
Zeitschriftenartikel
Simpson, Eric L.; Blauvelt, Andrew; Silverberg, Jonathan I.; Cork, Michael J.; Katoh, Norito; Mark, Thomas; Schneider, Shannon K. R. und Wollenberg, Andreas 
ORCID: https://orcid.org/0000-0003-0177-8722
(2024):
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1.
In: American Journal of Clinical Dermatology, Bd. 25, Nr. 1: S. 139-148
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-0177-8722
(2024):
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1.
In: American Journal of Clinical Dermatology, Bd. 25, Nr. 1: S. 139-148
[PDF, 1MB]
Simpson, Eric L.; Pink, Andrew E.; Blauvelt, Andrew; Gooderham, Melinda; Armstrong, April W.; Worm, Margitta; Katoh, Norito; Peris, Ketty; Puig, Luis; Barbarot, Sébastien; Mark, Thomas; Steffensen, Louise Abildgaard; Tindberg, Ann-Marie und Wollenberg, Andreas ORCID: https://orcid.org/0000-0003-0177-8722
(2023):
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
In: American Journal of Clinical Dermatology, Bd. 24, Nr. 6: S. 939-952
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-0177-8722
(2023):
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
In: American Journal of Clinical Dermatology, Bd. 24, Nr. 6: S. 939-952
[PDF, 2MB]
Simpson, Eric L.; Wollenberg, Andreas; Soong, Weily; Steffensen, Louise Abildgaard; Kurbasic, Azra; Schneider, Shannon; Zoidis, John und Silverberg, Jonathan I.
(2022):
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3).
In: Annals of Allergy Asthma & Immunology, Bd. 129, Nr. 5: S. 592-604
Paller, Amy S.; Simpson, Eric L.; Siegfried, Elaine C.; Cork, Michael J.; Wollenberg, Andreas; Arkwright, Peter D.; Soong, Weily; Gonzalez, Mercedes E.; Schneider, Lynda C.; Sidbury, Robert; Lockshin, Benjamin; Meltzer, Steven; Wang, Zhixiao; Mannent, Leda P.; Amin, Nikhil; Sun, Yiping; Laws, Elizabeth; Akinlade, Bolanle; Dillon, Myles; Kosloski, Matthew P.; Kamal, Mohamed A.; Dubost-Brama, Ariane; Patel, Naimish; Weinreich, David M.; Yancopoulos, George D.; O'Malley, John T. und Bansal, Ashish
(2022):
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
In: Lancet, Bd. 400, Nr. 10356: S. 908-919
Simpson, Eric L.; Merola, Joseph F.; Silverberg, Jonathan I.; Reich, Kristian; Warren, Richard B.; Staumont-Salle, Delphine; Girolomoni, Giampiero; Papp, Kim; Bruin-Weller, Marjolein de; Thyssen, Jacob P.; Zachariae, Rebecca; Olsen, Christiana K. und Wollenberg, Andreas
(2022):
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials.
In: British Journal of Dermatology, Bd. 187, Nr. 6: S. 888-899
Hall, Rebecca; Lebwohl, Mark G.; Bushmakin, Andrew G.; Simpson, Eric L.; Gooderham, Melinda J.; Wollenberg, Andreas; Gater, Adam; Wells, Jane R.; Cappelleri, Joseph C.; Hsu, Ming-Ann; Papacharalambous, Jocelyn; Peeva, Elena; Tallman, Anna M.; Zhang, Weidong und Chen, Linda
(2021):
Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD.
In: Dermatology and Therapy, Bd. 11, Nr. 1: S. 221-233
Silverberg, Jonathan I.; Simpson, Eric L.; Wollenberg, Andreas; Bissonnette, Robert; Kabashima, Kenji; DeLozier, Amy M.; Sun, Luna; Cardillo, Tracy; Nunes, Fabio P. und Reich, Kristian
(2021):
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders An Extension Study of 2 Randomized Clinical Trials.
In: Jama Dermatology, Bd. 157, Nr. 6: S. 691-699
Simpson, Eric L.; Paller, Amy S.; Siegfried, Elaine C.; Thaci, Diamant; Wollenberg, Andreas; Cork, Michael J.; Marcoux, Danielle; Huang, Rui; Chen, Zhen; Rossi, Ana B.; Shumel, Brad; Sierka, Debra und Bansal, Ashish
(2021):
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older.
In: Dermatology and Therapy, Bd. 11, Nr. 5: S. 1643-1656
Simpson, Eric L.; Wollenberg, Andreas; Bissonnette, Robert; Silverberg, Jonathan I.; Papacharalambous, Jocelyne; Zhu, Linda; Zhang, Weidong; Beebe, Jean S.; Vincent, Michael; Peeva, Elena; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Chen, Linda; Sikirica, Vanja und Xenakis, Jason
(2021):
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib.
In: Dermatitis, Bd. 32, Nr. 1S:
S53-S61
Simpson, Eric L.; Sinclair, Rodney; Forman, Seth; Wollenberg, Andreas; Aschoff, Roland; Cork, Michael; Bieber, Thomas; Thyssen, Jacob P.; Yosipovitch, Gil; Flohr, Carsten; Magnolo, Nina; Maari, Catherine; Feeney, Claire; Biswas, Pinaki; Tatulych, Svitlana; Valdez, Hernan und Rojo, Ricardo
(2020):
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
In: Lancet, Bd. 396, Nr. 10246: S. 255-266
Cork, Michael J.; Eckert, Laurent; Simpson, Eric L.; Armstrong, April; Barbarot, Sebastien; Puig, Luis; Girolomoni, Giampiero; de Bruin-Weller, Marjolein; Wollenberg, Andreas; Kataoka, Yoko; Remitz, Anita; Beissert, Stefan; Mastey, Vera; Ardeleanu, Marius; Chen, Zhen; Gadkari, Abhijit und Chao, Jingdong
(2019):
Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
In: Journal of Dermatological Treatment
Simpson, Eric L.; Bruin-Weller, Marjolein; Flohr, Carsten; Ardern-Jones, Michael R.; Barbarot, Sebastien; Deleuran, Mette; Bieber, Thomas; Vestergaard, Christian; Brown, Sara J.; Cork, Michael J.; Drucker, Aaron M.; Eichenfield, Lawrence F.; Fölster-Holst, Regina; Guttman-Yassky, Emma; Nosbaum, Audrey; Reynolds, Nick J.; Silverberg, Jonathan I.; Schmitt, Jochen; Seyger, Marieke M. B.; Spuls, Phyllis I.; Stalder, Jean-Francois; Su, John C.; Takaoka, Roberto; Traidl-Hoffmann, Claudia; Thyssen, Jacob P.; Schaft, Jorien van der; Wollenberg, Andreas; Irvine, Alan D. und Paller, Amy S.
(2017):
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
In: Journal of the American Academy of Dermatology, Bd. 77, Nr. 4: S. 623-633